WEIGHT LOSS WITH SEMAGLUTIDE AND TIRZEPATIDE
Obesity and Diabetes is indeed a major problem now-a-days and has led many people to other followed on diseases or to change their diet plans. I have years of experience handling & treating Obesity and Type II Diabetic issues. We believe in a solution oriented approach, hence providing special care & medical treatment to each patient. Semaglutide and Tirzepatide (GLP-1/GIP) are the breakthrough discoveries helping many people get rid of obesity and have proven to be the best weight loss treatments.
In Europe and the United States, semaglutide is approved in people with obesity (body mass index [BMI] ≥30 kg/m2) or those with overweight (BMI ≥27 to <30 kg/m2) and at least one weight-related comorbidity.
Semaglutide/Tirzepatide for Weight Loss - It works - What you should know.
Semaglutide is an injectable drug initially used as a diabetes medication. It was approved in 2014 to treat chronic weight loss. It is not a miracle drug and is not for everyone. Patients have reported 15% to 20% weight loss.
Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 receptor antagonists (GLP-1). It is released in the gut in response to eating. What it does: 1. Prompts the body to produce more insulin., 2. Reduces blood sugar., 3. Slow gut emptying which makes you feel full for longer. GLP-1 in higher amounts interacts with the brain to suppress the appetite and signals the gut when to feel full.
For those who are obese it also shows a reduced risk of cancer, diabetes and heart disease.
How it works is you inject a specific amount weekly subcutaneously. This injection is included with a healthier diet and exercise.
Side Effects can include but not with all patients: Dizziness, Fatigue, Gastrointestinal issues (diarrhea, constipation and gassiness), Headache, Stomach Issues (nausea, vomiting, pain, and bloating. Gastrointestinal issues are most common and can be reduced by starting at a low dose and slowly increasing.
Do not take Semaglutide if: History of medullary thyroid cancer, history of gallbladder disease, history of pancreatitis, Multiple endocrine neoplasia syndrome type 2.
Make it stand out.
“I lost 30 pounds in 6 weeks.” Patient 1